Toleranzia AB
Toleranzia AB is a technology portfolio for treatment of autoimmune diseases
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Toleranzia AB Information
Geographic Data
Address:
City: Gothenburg
State: Vastra Gotaland
Zip:
Country: Sweden
Financial Info
Stage:
grant
Raised Last:
$82k
Raised Total:$82k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Toleranzia develops drugs that utilize the immune system&s;s own intrinsic power to treat autoimmune orphan diseases. The drugs, which target the disease cause, can cure or greatly alleviate the disease and not just reduce the symptoms that current treatments do. The company&s;s drug candidate, TOL2, is developed for the autoimmune nerve and muscle disease myasthenia gravis.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Grant | 1 | $81.9k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
